Anti-Epileptics Flashcards

1
Q

Definitions
seizure
epilepsy
status epilepticus

A

Seizure
- abnormal neruonal firing in the cortex: physical or sensory manifestation
- an acute neurological event
- diferent types, severity, apperance based on location of firing
- a seizure does NOT = epiliepsy dx.

Epilepsy
- the occurance of 2+ seizures separated by at LEASE 24 hours
- a chronic, recurring disorder with an underlying process

Status Epilepticus
- any seziure last > 5 minutes : this is when neuronal damange can occur
- or any 2 seizures happening without complete recovery or consciousness/recovery of first seizure between

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do you select the proper drug for seizure management

A
  1. identify the underlying cause of the seizure: if its due to hypoglycemia: give dextrose!
  2. type of seizure (tonic-clonic, absence, etc.) guides
  3. MOA of drug: if on multiple: want different MOAs
  4. ADE: of the meds can guide therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are some medications that can worsen seizure
the common ones
& ones to be aware of

A

Common meds to cause/worsen seizures
- meperidine (opioid)
- flumazemil (benzo reversal agent)
- contrast dyes!!
- vaccines
- phenothiazines (anti-psychotics)

Imipenem = can reduce seizure threshold
buproprion = can lower seizure threshold
withdrawl from benzos, alcohol and opioids can worsen seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MOA: Sodium channel antagonism

A

MOA
- these AED’s will antagonize the sodium channels: prolonging the inactivity and ability for the Na+ channels to open
- this then reduces the ability of a neuron to fire = decreasing excitabilty and propagation of APs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MOA: Calcium Channel Modulators

A

MOA
- these drugs antagonize the calcium channel (N-type)
- they prevent the channels from releasing Ca+
- if Ca+ cannot be releasd: then there is no ability for the vesicel full of glutamate to fuse to the cleft and release into the synapse
- without the release of glutamate: there can be no excitatory potentiation down the cleft: no depolarizaiton

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA: drugs that act on GABA

A

GABA: an inhibitory NT

some drugs = enhance GABA: thus inhibiting the ability for an AP to occur, decrease excitability
some drugs = inhibit GABA-transaminase: thus inhibiting the breakdown of GABA: leading to more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what AED (anti-epileptic drugs) can be used for an Absence seizure

A

EL VZ!!

E: ethosuximide (can ONLY be used for absence seizures)
L: Lamotrigine
V: Valproate
Z: Zonisamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what AED’s must be AVOIDED in myoclonic and absence seizures

A

AVOID the following for absence and myoclonic seizures
- carbamazepine
- oxcarbmazepine
- gabapentin
- tiagabine
- pregabalin

these will all exacerbate the seizure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

role of benzodiazepines in seizure control
what is used for status epi. vs. what is used for add-on

A

Reserved for Status Epi.
- Lorazepam
- midazolam
- diazepam

Used for Add-on to gain control with AED
- clonazepam
- clobazam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Benzodiazepines
MOA
Indications (seizure and other)

A

Benzodiazepines: MOA
- bind to post-synaptic GABA A receptors: increase the inhibition that GABA gives

Indications
- Benzos are first line in status epilepticus (lorazepam, midazalam, diazepam)
- can be used for focal or general seizures (clonazepam, clobazam)
- can be used to control Lennox-Gastuat (a seizure syndrome)

Additional Indications
- anxiety, insomnia, ICU sedation, alcohol withdrawl, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Benzodiazepines
side effects
monitoring
Drug interactions

A

Side Effects/ADR
- respiratory depression : in status epi. youll intubate because you’re giving in such high doses
- drowsiness
- ataxia
- hypotension: dose-related, propylene glycol can be given with lorazepam and diazepam to help decrease this effect
- watch for withdrawal symptoms upon abrupt discontinuation: taper off

Monitoring
- watch RR: work of breathing, O2 status
- mental stauts & neuro exam
- BP! wathc for hypotension

Drug Interactions
- no monitoring needed
- watch interactions with otehr CNS depressants (opioids, alcohol,etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Carbamazepine
MOA
Uses
Adverse Effects /ADR

A

Carbamazepine: AED (Tegretol)
- fast sodium channel inactivator with active metabolite also inactiving the Na+ channel

Uses
- focal and general seizures (no absence)
- bipolar disorder
- trigeminal neuralgia
- neuropathic pain

ADR
- these are all concentration dependent
- diplopia, drowsiness and sedation
- slgnificant N/V
- leukopenia
- Aplastic anemia
- hyponatermia
- rash: SJS risk
- decreased BMD
- teratogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Carbamazepine
Contraindications to Use
Monitoring Parameters
what about metabolism

A

Contraindiciations
- bone mineral density suppression: depression
- use of MAO within 14 days
- using nefaxdone
- using NNRTI (HIV med)
- presence of the HLA-B 1502 gene: if you CANNOT TEST FOR THIS; you CANNOT USE this med

Monitoring
- drug level 4-12mcg/mL
- must screen for HLA-B1502 gene
- monitor CBC: WBC > 2,500 & ANC > 1,000
- Na: keep 135-145

Metabolism
Carbamazepine is an AUTOinducer:meaning it will metabolize itself quicky at 3A4 then over time level out
- increase dose every week until adequte concentration
- starts 3- 5days; ends 21-28 : check levels weekly for first 3-5 weeks

PT. MUST BE ON FOLIC ACID 1-4 MG DOSING IF THEY ARE ON CARBAMAZEPINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Oxcarbazepine
MOA
Indications

A

MOA
- a prodrug: converted and then its metabolite inactivates fast sodium channels

Indications
- generalized and focal seizures
- can be usd in those not responding to carbamaizepine

Side Effects
- well tolerated
- diplopid, dizzty, somnelence
- rash: watch if they had it to carbamaz. they’ll probs have it here too
- hyponatremia: more likely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Oxcarbazepine
monitoring
metabolism

A

Monitoring
- no therapeudic monitoring needed
- watch neuro exam
- watch sodium levels

Metabolism
- no autoinduction
- this drug can decrease the bioavalibility of estrogen in OCP medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ethosuximide
MOA
Indications (specific)
Side Effects
Monitoring

A

Ethosuximide:MOA
- a calcium channel modulator

Indications
only used for absence seizures!!!!! : the first-line medication

Side Effects
- well tolerated
- N/V
- ataxia and sedation
- neutropenic: monitor CBC
- rash
- hepatoxicity

Monitoring
drug levels should be 40-100mcg/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Felbamate
MOA
Indications (specific)
Side Effects
Drug Interactions
Contraindication!!

A

Felbamate: MOA
- glutamate activity inhibitor

Indications
- LAST LINE CHOICE: use for pt. who are not responding to other agents

Side Effects (many = hence last line)
- anxiety/insomnia
- nausea
- weight loss
- HA severe
- Aplastic anemia: need to monitor CBC
- Acute liver failure: monitor LFTs

Drug Interactions
- increased CNS depressant with others
- no monitoring of levels needed

Contraindication
- hisotry of blood disorder (dyscrasias)
- history of hepatic dysfunction

18
Q

Gabapentin (neurontin)
MOA
Indications
Side Effects

A

Gabapentin: MOA
- enhances GABA inhibition activity
- modulates calcium channels

Indications
- used for focal and general seizures (usually adjuct)
- used on elderly
- post-herpetic neuralgia
- neuropathic pain
- diabetic neuropathy

Side Effects
- well tolerated
- sedation/drowsy
- peripheral edema & weight gain
- on withdrawal: anxiety, insomnia, nausea, sweating etc. (syndrome)

Pearls
- no monitoring, contraindications, enzyme issues
- watch in renal: need to renally adjust

19
Q

Lacosamide
MOA
Indications
Side Effects

A

Lacosamide: MOA
- slow sodium channel inactivation

Indications
- can be indicated for those who failed other sodium channel blocking meds (phenytoin)
- focal seziures
- last line salvage in status. epi.

Side Effects
- dizzy, diplopia, N/V, HA
- increased LFTs : monitor
- PR interval prolongation: EKG

due to prolonged PR: caution use in those with 2nd or 3rd degree heart block

20
Q

Lamotrigine
MOA
Indications
Side Effects

A

Lamotragine: MOA
- fast sodium channel inactivation

Indications
- absence seizures
- focal, tonic-clonic and general
- bipolar disorder too

Side Effects
- drowsy, HA, diplopia, insomnia, etc.
- Rash: within 3-4 weeks and can progress to SJS
- rash seen more commonly with concurrent use of valproic acid + lamotragine

Drug Intercations
- lamotragine decreases the levogresterol component in OCPS
- ethinyl estradiol impacts lamotragine
- if used with carbamaziepine: CNS effects

21
Q

Levetiracetam (Keppra)
MOA
Indications
Side Effects
Elimination

A

Levetiracetam: MOA
- modulates synaptic vescile protien

Indications
- focal & general: very good with seizures treatment and preventing

Side Effects
- sedation, dizzy, depression
- hallucinations: agitation and psychosis if underlying psych. disease

Metabolism
- renally eliminated: adjust as needed

22
Q

Phenobarbital
MOA
Indications
Side Effects

A

Phenobarbital: MOA
- fast sodum channel inactivator

Indications
- general or focal seizures

SIde Effects
- ataxia, droswy, sedation (significant!)
- hyperactivity in some pt.
- osteoporosis
- rash
- blood disorders: agranulocytosis, thrombocyotpenia, megaloblastic anemia

23
Q

Phenobarbital
Contraindications
Monitoring levels
Drug Interactions

A

Contraindications
- hepatic dysfunction
- airway issues/dyspena
- history of sedative/hyponotic abiuse
- nephritic pt.

Monitoring
goal 15-40 mcg/mL
- CBC
- neuro exam

Drug Interactions
- strong CYP - 3A4 inducer: speeds up metabolism of lots of meds
- ethanol will increase metabolism of pehnobarb.
- cimetidine will decrease metabolism

24
Q

Phenytoin (Dilantin)
MOA
Indications
SE (by level) and general

A

Phenytoin: MOA
- fast sodum channel inhibitor

Indications
- status epi: use
- focal or general seizures

Side Effects: depend on concentration
- all: dizzy, diplopia, drowsy sedation
- normal levels 10-20
- > 20 = nystagmus
- > 30 = ateral nystagmus and ataxia
- > 40 = decreased mentation
- > 100 = death

other SE
- anemia
- gingival hyperplasia
- hirsutism
- lymphadenopathy
- osteporosis
- rash
- hepatotoxic
- teratogenic

25
Q

Phenytoin
Concentration and plasma
monitoring
difference between free and bound

A

Concentration Considerations
- phenytoin will be 95% bound to the plamsa albumin protein
- but there is a nonlinear relationship between dose and concentration
- as the dose increases, the body can no longer metabolize it as fast, so you get increased serum concentrations once fully saturated in its bound to plasam form
- small chages in dose of phenytoin can lead to large changes in serum concentration

Monitoring
- monitor tough levels (before next dose)
- TOTAL phenyotoin (bound and unbound) = 10-20
- FREE phenyotoin (unbound) = 1-2

TOTAl levels: can be falsely low in those with low albumin: seems ok but when you do the free levle you see there SO much unbound (thus active) that you get bad SE

26
Q

Equation for Free and Total Phenyotinin levels

A

check a free level in
- hypoalbuminemia
- reanl failure
- pregnant
- critically ill
- babies
- those with lots of protein bound drugs

For Hypoalbuminemia
adjusted = TOTAL concentration/ (0.2 x albumin) + 0.1

For CrCl < 10
adjusted = TOTAL concentration/ (0.1 x albumin) + 0.1

if calculating both: dose ajust base on whichever one is worse

27
Q

Phenytoin
drug interactions
contraindications to IV phenytoin

A

Phenytoin Drug INteractions
major substart at 2C9 and 19
induces 3A4

highly preotien bound drug: so drug interactions can occur with other drugs that are highly bound as well

Contraindication to IV Phenyotoin
- sinus brday
- SA block
- 2nd and 3rd degree heart block

28
Q

Pregabalin
MOA
Indications

A

Pregabalin: MOA
- calcium channel modulator

Indications
- focal seizure adjuct
- fibromyaliga
- postherpetic nerualgia
- neuropathic pain
- controlled substance

Side effets
- dizzy, sedation, dry mouth, blurry vision
- peripheal edema & weight gain
- wihtdrawl syndrome possible

Pearls
- renally eliminated: dose
- no drug interactions or monitoring

29
Q

Tiabaine
MOA
Indications
Side Effects
Drug Interactions

A

MOA
- enhances GABA

Indication
- add on for focal seizures

SIde Effects
- dizzy
- sonolence
- slow thinking
- CNs depressant

Drug Interactions
- major CYP 3A4 substarte: watch with inducers/inhibitors

30
Q

Toperimate
MOA
Indications
Side Effects
Drug Indications

A

Toperimate: MOA
- fast sodium channel inactivtion
- enhances GABA activity
- inhibits glutamate activity

Indications
- focal and general seziures
- migraine prophylaxis

Side Effects
- ataxia, dizzy, drowsy
- acute angle glaucoma
- ** renal calculi**

Contraindications
- with extended release: no alcohol within 6 hours; risk of metabolic acidosis if taking metformin

Drug Interactions
- increases etrogen clearance
- carbamazepine, phenytoin and valporate can decrease toperimate concentrations

31
Q

Valproic Acid
Types
MOA
Indications

A

Valproic Acid: Types
- immediate release med: Depakene
- delayed release: stavzor
- IV: valproate sodium
- enteric coated
- bioavaiblity between formulations varies

MOA
- fast sodium channel inactivation

Indications
- for all seizures
- migraine prophylaxis
- mania
- diabetic neuropathy

32
Q

Valproic Acid
Side Effects
Monitoring
Contraindications

A

Teratogenic

Side Effects
- nausea, drowsy
- tremor
- acute hepatotoxicity
- acute pancreatitis
- osteperosis
- weight gain

Monitoring
trough: 50-100

Contraindications
- hepatic dz. pt.
- urea cycle disorders
- mitochondrail disorders
- pregnant pt.

33
Q

Valproic Acid
Drug Interactions

A

Drug Interactions
- highly protein bound drug: watch interaction with phenytoin!
- oral contraceptives increase clearance of valproic acid
- valproic acid levels can be decreases by carbapenems
- additive effects of CNS depressants

34
Q

Vigabatrin
MOA
Indications
Side Effects

A

Vigabatrin: MOA
- GABA transaminase

Indications
- only for REFRACTORY foacl onset seizures
- you NEED to D/C this med in anyone with subclinical benefits

Side Effects
- convulsions
- dizzy
- HA
- weight gain
- permanent vision loss and blindness DOES HAPPEN

35
Q

Vigabatrin
Monitoring Parameters

A

Monitoring
- vision assessment: at baseline, before 4 weeks of administeration, then every 3 months AND 3-6 months after d/c med

no monitoring of levels
no contraindications

36
Q

Zonisamide
MOA
Indications
Side Effects
Contraindications

A

Zonisamide: MOA
- sodum and calcium channels

Indications
- foacl onset seizures

Side Effects
- dizzy, somnolence
- metabolic acidosis
- oligohydrosis
- paresthesias
- renal calculi

Contraindications
SULFONAMIDE ALLERGY!!

37
Q

Cost Issues with AEDs

A
  • rx. can be made for BRAND NAME only if necessary : since sometimes the bioavalibility varies and pt. can be sensitive
38
Q

Drug Levels to Know

waht two drugs clearance from the body are increased with OCP use

A

Carbamazpine ; 4-12
Ethosuximide: 40-100
phenobarbital: 15-40
phenyotoin: 10-20 (total) 1-2 bound
valproic acid: 50-100

OCP use: increases clearance of valproic acid and lamotrigine

39
Q

Teratogencity
which meds are
how much folic acid

A

Valproic Acid
Carbamazpine

these have risk of neural tube defects and hypospadias

Barbituates (phenobarb) & phenytoin
- heart defects, cleft lipe and others

women of childbearing age = MUST take 1-4 mg of folic acid daily if on these (or any AED) med

40
Q

Osteoporosis and malacia with AEDs

A

chronic AED use = increased risk

phenyotoin, phenobarbital, carbamazepine, valproic acid

add cacium and Vit D after 6montsh of therapy to decrease risk

41
Q

D/C medications of AED
how is it done

A

AED withdrawal can be considered for those meeting ALL THE FOLLOWING CRITERIA!!!
- extended period of seizure free (2 years if absence, 5 years if others)
- normal neuro exam
- normal IQ
- normal EEG
- single type of seizure dx.

how to D/c
- slow taper over 1-3 months
- 60% chance they will remain seizure free